LINC02196

Across TCGA pan-cancer cohorts, LINC02196 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02196’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC02196 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02196 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

HNSC, BRCA, and LUAD are the cancer types where LINC02196 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02196 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.120	.005	8	view →
BRCA	Female	All	+0.109	.012	4	view →
LUAD	All	All	+0.302	.003	3	view →
LUSC	Male	All	+0.264	.009	3	view →
KICH	All	III,IV	−0.120	.024	2	view →
LIHC	All	All	+0.073	.015	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02196–HNSC

Open the HNSC breakdown →